$6.17
-0.18[-2.83%]
Last update: 9:30AM Get Real Time Here
Relay Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Relay Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | PM | RLAY | Q1 | -$0.78 | -$0.71 | — | — | $226.00K | $30.00K | — | — | Get Alert |
02/22/2024 | PM | RLAY | Q4 | -$0.56 | -$0.73 | -$0.67 | 8.22% | $253.00K | $130.00K | $0.00 | -100.00% | Get Alert |
11/02/2023 | PM | RLAY | Q3 | -$0.76 | -$0.83 | -$0.54 | 34.94% | $344.00K | — | $25.20M | — | Get Alert |
08/08/2023 | PM | RLAY | Q2 | -$0.71 | -$0.81 | -$0.81 | 0.00% | $365.00K | $750.00K | $119.00K | -84.13% | Get Alert |
05/04/2023 | PM | RLAY | Q1 | -$0.57 | -$0.69 | -$0.78 | -13.04% | $419.00K | $210.00K | $226.00K | 7.62% | Get Alert |
02/23/2023 | PM | RLAY | Q4 | -$0.62 | -$0.70 | -$0.56 | 20.00% | $567.00K | $3.30M | $253.00K | -92.33% | Get Alert |
11/03/2022 | PM | RLAY | Q3 | -$0.66 | -$0.71 | -$0.76 | -7.04% | $666.00K | $1.66M | $344.00K | -79.28% | Get Alert |
08/04/2022 | PM | RLAY | Q2 | -$0.64 | -$0.63 | -$0.71 | -12.70% | $844.00K | $1.93M | $365.00K | -81.09% | Get Alert |
05/05/2022 | PM | RLAY | Q1 | -$0.47 | -$0.62 | -$0.57 | 8.06% | $952.00K | $170.00K | $419.00K | 146.47% | Get Alert |
02/24/2022 | PM | RLAY | Q4 | $4.52 | — | -$0.62 | — | $82.65M | — | $567.00K | — | Get Alert |
11/10/2021 | PM | RLAY | Q3 | -$3.00 | -$0.64 | -$0.66 | -3.12% | $0.00 | $110.00K | $666.00K | 505.45% | Get Alert |
08/12/2021 | PM | RLAY | Q2 | — | -$0.45 | -$0.64 | -42.22% | — | $8.00M | $844.00K | -89.45% | Get Alert |
05/13/2021 | PM | RLAY | Q1 | -$5.99 | -$0.48 | -$0.47 | 2.08% | — | $952.00K | $952.00K | 0.00% | Get Alert |
03/25/2021 | PM | RLAY | Q4 | — | — | $4.52 | — | — | — | $82.65M | — | Get Alert |
11/12/2020 | PM | RLAY | Q3 | -$5.53 | -$0.35 | -$3.00 | -757.14% | — | — | $0.00 | — | Get Alert |
Relay Therapeutics (RLAY) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 22, 2024 for Q4.
The Actual EPS was $-0.67, which beat the estimate of $-0.73.
The Actual Revenue was $0K, which missed the estimate of $130K.
Browse earnings estimates, EPS, and revenue on all stocks.